“…The effect of the pandemic on thoracic surgery was very notable, especially given that the main volume of this specialty is the treatment of lung cancer, a pathology whose treatment cannot be delayed. 8 Across Europe, there was a general decrease in surgical volume, as well as in multidisciplinary meetings and tumor committees for the treatment of lung cancer. 9 In Spain, the effects were even greater in many cases, as our country was one of the most affected by the first wave of the virus.…”